Jill S Barnholtz-Sloan
Overview
Explore the profile of Jill S Barnholtz-Sloan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
343
Citations
23571
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Selvaraj R, Cioffi G, Waite K, Jackson S, Barnholtz-Sloan J
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941747
Background: In cancer, age and sex are often studied individually, but the impact of the intersection of these factors on cancer incidence and survival remains unclear. Using population-level data, we...
2.
Nowicka Z, Rentzeperis F, Tagal V, Teer J, Ilter D, Beck R, et al.
Cancer Res
. 2025 Feb;
PMID: 39933186
Glioblastoma (GBM) is the most aggressive form of primary brain tumor. The infiltrative nature of GBM makes complete surgical resection impossible. The selective forces that govern gliomagenesis are strong, shaping...
3.
Landry A, Wang J, Liu J, Patil V, Gui C, Patel Z, et al.
Neuro Oncol
. 2025 Jan;
PMID: 39775867
Background: Meningiomas exhibit considerable clinical and biological heterogeneity. We previously identified four distinct molecular groups (immunogenic, NF2-wildtype, hypermetabolic, proliferative) that address much of this heterogeneity. Despite the utility of these...
4.
Akbari H, Bakas S, Sako C, Kazerooni A, Villanueva-Meyer J, Garcia J, et al.
Neuro Oncol
. 2024 Dec;
PMID: 39665363
Background: Glioblastoma is the most aggressive adult primary brain cancer, characterized by significant heterogeneity, posing challenges for patient management, treatment planning, and clinical trial stratification. Methods: We developed a highly...
5.
Chen Z, Kim E, Davidsen T, Barnholtz-Sloan J
JCO Clin Cancer Inform
. 2024 Nov;
8:e2400116.
PMID: 39536277
Purpose: Over the past decade, significant surges in cancer data of all types have happened. To promote sharing and use of these rich data, the National Cancer Institute's Cancer Research...
6.
Landry A, Wang J, Patil V, Gui C, Yasin M, Patel Z, et al.
Neuro Oncol
. 2024 Nov;
PMID: 39503370
Background: We previously developed a DNA methylation-based risk predictor for meningioma, which has been used locally in a prospective fashion since its original publication. As a follow-up, we validate this...
7.
Bao R, Hutson A, Madabhushi A, Jonsson V, Rosario S, Barnholtz-Sloan J, et al.
J Immunother Cancer
. 2024 Oct;
12(10).
PMID: 39461879
Immuno-oncology has transformed the treatment of cancer, with several immunotherapies becoming the standard treatment across histologies. Despite these advancements, the majority of patients do not experience durable clinical benefits, highlighting...
8.
Walsh K, Price M, Raleigh D, Calabrese E, Kruchko C, Barnholtz-Sloan J, et al.
J Natl Cancer Inst
. 2024 Oct;
117(2):366-374.
PMID: 39392420
Background: Meningioma risk factors include older age, female sex, and being Black/African American. Limited data explore how meningioma risk in individuals who are Black varies across the lifespan, interacts with...
9.
Price M, Ballard C, Benedetti J, Neff C, Cioffi G, Waite K, et al.
Neuro Oncol
. 2024 Oct;
26(Supplement_6):vi1-vi85.
PMID: 39371035
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and the National Cancer Institute, is the largest population-based registry...
10.
Dmukauskas M, Cioffi G, Waite K, Mammoser A, Sloan A, Ma P, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272844
Sex differences are evident in adverse events (AEs) related to brain tumors, yet sex differences in AEs specific to brain metastases (BrMs) are underexplored. Lung cancer BrMs dominate among BrM,...